Ultragenyx Pharmaceutical (RARE) Q4 2024 Earnings

5NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-2.03
-1.82
-1.61
-1.4

Details

Expected EPS
-1.483941
Actual EPS
-1.4
Surprise EPS
0.08
Surprise Percent
+5.66%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.4 per share for Q4 2024.

0 Comments

Share your thoughts